Y-Mabs Therapeutics Inc (YMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | YMAB | CTNM | MNPR | ||
| Company | Y-Mabs Therapeutics Inc | Contineum Therapeutics Inc | Monopar Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.59 | 13.50 | 57.76 | ||
| High | 8.61 | 15.00 | 58.85 | ||
| Low | 8.59 | 13.13 | 56.04 | ||
| Latest | 8.61 | 14.98 | 57.00 | ||
| Change | +0.02 | +1.57 | -1.51 | ||
| % Change | +0.23% | +11.71% | -2.58% | ||
| Volume | 760,600 | 250,400 | 179,400 | ||
| 20-Day Average Volume | 874,510 | 205,365 | 180,655 | ||
| Previous Close | 8.59 | 13.41 | 58.51 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 8.56 | 14.92 | 56.01 | ||
| 20-Day Raw Stochastic | 100.00% | 57.81% | 59.32% | ||
| 20-Day Relative Strength | 77.65 | 54.89 | 45.18 | ||
| Weighted Alpha | -45.79 | +105.31 | +21.17 | ||
| Today's Opinion | 88% Buy | 88% Buy | 56% Sell | ||
| Previous Opinion | 88% Buy | 72% Buy | 56% Sell | ||
| Last Month's Opinion | 56% Buy | 100% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.23% since 09/08/25 | +0.81% since 03/04/26 | +2.72% since 03/04/26 | ||
| Low | 8.57 on 09/11/25 | 13.13 on 03/11/26 | 53.50 on 03/06/26 | ||
| High | 8.61 on 09/15/25 | 15.02 on 03/06/26 | 60.09 on 03/10/26 | ||
| 1-Month | |||||
| %Chg | +1.06% since 08/15/25 | -1.83% since 02/11/26 | -4.02% since 02/11/26 | ||
| Low | 8.51 on 08/18/25 | 13.13 on 03/11/26 | 50.73 on 03/03/26 | ||
| High | 8.61 on 09/15/25 | 16.33 on 02/24/26 | 61.30 on 02/24/26 | ||
| 3-Month | |||||
| %Chg | +82.80% since 06/13/25 | +14.61% since 12/11/25 | -26.02% since 12/11/25 | ||
| Low | 3.90 on 06/20/25 | 8.60 on 01/08/26 | 50.73 on 03/03/26 | ||
| High | 8.61 on 09/15/25 | 16.33 on 02/24/26 | 77.45 on 12/15/25 | ||
| 6-Month | |||||
| %Chg | +84.37% since 03/14/25 | +26.84% since 09/11/25 | +19.58% since 09/11/25 | ||
| Low | 3.55 on 05/15/25 | 8.60 on 01/08/26 | 45.52 on 09/12/25 | ||
| High | 8.61 on 09/15/25 | 16.33 on 02/24/26 | 105.00 on 10/06/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 391,221 | 391,344 | 390,999 | ||
| Shares Outstanding, K | 45,438 | 29,183 | 6,683 | ||
| Annual Sales | 87,690,000 | 0 | 0 | ||
| Annual Net Income | -29,670,000 | -59,980,000 | -15,590,000 | ||
| Last Quarter Sales | 19,530,000 | 0 | 0 | ||
| Last Quarter Net Income | -3,240,000 | -15,160,000 | -3,440,000 | ||
| 60-Month Beta | 0.53 | 1.07 | 1.58 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 08/08/25 | -0.45 on 10/30/25 | -0.48 on 11/13/25 | ||
| Latest Earnings Date | 11/14/25 | 05/13/26 | 03/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||